vs

Side-by-side financial comparison of Innoviz Technologies Ltd. (INVZ) and NATURAL HEALTH TRENDS CORP (NHTC). Click either name above to swap in a different company.

Innoviz Technologies Ltd. is the larger business by last-quarter revenue ($15.3M vs $9.7M, roughly 1.6× NATURAL HEALTH TRENDS CORP). NATURAL HEALTH TRENDS CORP runs the higher net margin — -6.0% vs -100.9%, a 94.9% gap on every dollar of revenue. NATURAL HEALTH TRENDS CORP produced more free cash flow last quarter ($-964.0K vs $-14.0M).

Luminar Technologies Inc. was an American technology company that developed vision-based lidar and machine perception technologies, primarily for self-driving cars. The company's headquarters and main research and development facilities were in Orlando, Florida; a second major office was located in Palo Alto, California.

Sword Health is a digital health company that develops physical therapy programs for musculoskeletal (MSK) conditions, pelvic health, and injury prevention. The company was founded in 2015 in Portugal by Virgílio Bento and Márcio Colunas. Its services include digital physical therapy with artificial intelligence (AI) integrated into the care model. As of 2024, Sword Health operates internationally, with offices in the United States, Ireland, and Portugal. The company has been valued at $3 bil...

INVZ vs NHTC — Head-to-Head

Bigger by revenue
INVZ
INVZ
1.6× larger
INVZ
$15.3M
$9.7M
NHTC
Higher net margin
NHTC
NHTC
94.9% more per $
NHTC
-6.0%
-100.9%
INVZ
More free cash flow
NHTC
NHTC
$13.1M more FCF
NHTC
$-964.0K
$-14.0M
INVZ

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
INVZ
INVZ
NHTC
NHTC
Revenue
$15.3M
$9.7M
Net Profit
$-15.4M
$-588.0K
Gross Margin
15.0%
72.9%
Operating Margin
-103.4%
-6.5%
Net Margin
-100.9%
-6.0%
Revenue YoY
-10.1%
Net Profit YoY
-434.1%
EPS (diluted)
$-0.08
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INVZ
INVZ
NHTC
NHTC
Q4 25
$9.7M
Q3 25
$15.3M
$9.5M
Q2 25
$9.8M
Q1 25
$10.7M
Q4 24
$10.8M
Q3 24
$10.7M
Q2 24
$10.5M
Q1 24
$11.0M
Net Profit
INVZ
INVZ
NHTC
NHTC
Q4 25
$-588.0K
Q3 25
$-15.4M
$-431.0K
Q2 25
$15.0K
Q1 25
$122.0K
Q4 24
$176.0K
Q3 24
$35.0K
Q2 24
$173.0K
Q1 24
$188.0K
Gross Margin
INVZ
INVZ
NHTC
NHTC
Q4 25
72.9%
Q3 25
15.0%
73.7%
Q2 25
73.9%
Q1 25
73.6%
Q4 24
74.2%
Q3 24
74.1%
Q2 24
74.2%
Q1 24
73.4%
Operating Margin
INVZ
INVZ
NHTC
NHTC
Q4 25
-6.5%
Q3 25
-103.4%
-5.2%
Q2 25
-3.4%
Q1 25
-3.2%
Q4 24
-3.9%
Q3 24
-2.6%
Q2 24
-2.3%
Q1 24
-3.3%
Net Margin
INVZ
INVZ
NHTC
NHTC
Q4 25
-6.0%
Q3 25
-100.9%
-4.5%
Q2 25
0.2%
Q1 25
1.1%
Q4 24
1.6%
Q3 24
0.3%
Q2 24
1.7%
Q1 24
1.7%
EPS (diluted)
INVZ
INVZ
NHTC
NHTC
Q4 25
$-0.05
Q3 25
$-0.08
$-0.04
Q2 25
$0.00
Q1 25
$0.01
Q4 24
$0.01
Q3 24
$0.00
Q2 24
$0.02
Q1 24
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INVZ
INVZ
NHTC
NHTC
Cash + ST InvestmentsLiquidity on hand
$17.3M
$28.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$89.7M
$23.4M
Total Assets
$151.1M
$38.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INVZ
INVZ
NHTC
NHTC
Q4 25
$28.9M
Q3 25
$17.3M
$32.0M
Q2 25
$34.2M
Q1 25
$41.9M
Q4 24
$43.9M
Q3 24
$46.3M
Q2 24
$48.7M
Q1 24
$54.4M
Stockholders' Equity
INVZ
INVZ
NHTC
NHTC
Q4 25
$23.4M
Q3 25
$89.7M
$26.1M
Q2 25
$28.9M
Q1 25
$30.9M
Q4 24
$32.9M
Q3 24
$35.3M
Q2 24
$37.3M
Q1 24
$39.4M
Total Assets
INVZ
INVZ
NHTC
NHTC
Q4 25
$38.4M
Q3 25
$151.1M
$42.3M
Q2 25
$45.2M
Q1 25
$53.2M
Q4 24
$55.4M
Q3 24
$58.3M
Q2 24
$61.5M
Q1 24
$67.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INVZ
INVZ
NHTC
NHTC
Operating Cash FlowLast quarter
$-13.7M
$-959.0K
Free Cash FlowOCF − Capex
$-14.0M
$-964.0K
FCF MarginFCF / Revenue
-91.7%
-9.9%
Capex IntensityCapex / Revenue
1.9%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INVZ
INVZ
NHTC
NHTC
Q4 25
$-959.0K
Q3 25
$-13.7M
$113.0K
Q2 25
$-5.6M
Q1 25
$484.0K
Q4 24
$88.0K
Q3 24
$-436.0K
Q2 24
$-3.6M
Q1 24
$549.0K
Free Cash Flow
INVZ
INVZ
NHTC
NHTC
Q4 25
$-964.0K
Q3 25
$-14.0M
$70.0K
Q2 25
$-5.6M
Q1 25
$468.0K
Q4 24
$68.0K
Q3 24
$-443.0K
Q2 24
$-3.6M
Q1 24
$538.0K
FCF Margin
INVZ
INVZ
NHTC
NHTC
Q4 25
-9.9%
Q3 25
-91.7%
0.7%
Q2 25
-57.5%
Q1 25
4.4%
Q4 24
0.6%
Q3 24
-4.1%
Q2 24
-34.2%
Q1 24
4.9%
Capex Intensity
INVZ
INVZ
NHTC
NHTC
Q4 25
0.1%
Q3 25
1.9%
0.5%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.2%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.1%
Cash Conversion
INVZ
INVZ
NHTC
NHTC
Q4 25
Q3 25
Q2 25
-375.67×
Q1 25
3.97×
Q4 24
0.50×
Q3 24
-12.46×
Q2 24
-20.62×
Q1 24
2.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons